SEC Filing | Nautilus, Inc.

View:

nls-20210930

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



FORM			10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-31321



NAUTILUS, INC.
(Exact name of Registrant as specified in its charter)


Washington						94-3002667
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

17750 S.E. 6th Way

Vancouver, Washington 98683

(Address of principal executive offices, including zip code)

(360) 859-2900

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value	NLS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

[ ]

Accelerated Filer

[x]

Non-accelerated filer

[ ]

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No [x]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

The number of shares outstanding of the registrant's common stock as of November 5, 2021 was 31,176,246 shares.

NAUTILUS, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021


	PART I
Item 1.	Financial Statements	1
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	38
Item 4.	Controls and Procedures	38

	PART II
Item 1.	Legal Proceedings	39
Item 1A.	Risk Factors	39

Item 6.	Exhibits	40
Signatures		41

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NAUTILUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited and in thousands)


	As of
	September 30, 2021		March 31, 2021
Assets
Cash and cash equivalents	$	20,179	$	38,441
Restricted cash	1,339		1,339
Available-for-sale securities	—		73,448
Trade receivables, net of allowances of $1,065 and $1,177	88,712		88,657
Inventories	162,669		68,085
Prepaids and other current assets	13,120		25,840
Income taxes receivable	2,404		—


Total current assets	288,423		295,810
Property, plant and equipment, net	29,463		24,496
Operating lease right-of-use assets	24,540		19,108
Goodwill	24,508		—
Other intangible assets, net	9,334		9,365
Deferred income tax assets, non-current	2,950		2,144
Income taxes receivable, non-current	5,673		—
Other assets - restricted, non-current	3,887		—
Other assets	2,252		3,307
Total assets	$	391,030	$	354,230
Liabilities and Shareholders' Equity
Trade payables	$	115,238	$	98,878
Accrued liabilities	22,402		19,627
Operating lease liabilities, current portion	4,766		3,384
Warranty obligations, current portion	5,899		7,243
Income taxes payable, current portion	595		5,709
Debt payable, current portion, net of unamortized debt issuance costs of $83 and $83	3,250		3,000

Total current liabilities	152,150		137,841
Operating lease liabilities, non-current	22,006		17,875
Warranty obligations, non-current	1,467		1,408
Income taxes payable, non-current	3,990		3,657

Other non-current liabilities	4,908		607
Debt payable, non-current, net of unamortized debt issuance costs of $194 and $236	13,998		10,297
Total liabilities	198,519		171,685
Commitments and contingencies (Note 16)
Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 31,159 and 30,576 shares issued and outstanding	3,058		2,176
Retained earnings	189,806		180,524

Accumulated other comprehensive loss	(353)		(155)
Total shareholders' equity	192,511		182,545
Total liabilities and shareholders' equity	$	391,030	$	354,230

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except per share amounts)


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Net sales	$	137,959	$	155,391	$	322,552	$	269,579
Cost of sales	95,906		87,453		224,994		154,245
Gross profit	42,053		67,938		97,558		115,334
Operating expenses:
Selling and marketing	21,939		19,207		43,239		31,653
General and administrative	16,376		8,841		27,899		18,156
Research and development	5,688		4,240		10,503		7,968
(Gain) loss on disposal group	—		(8,345)		—		20,668

Total operating expenses	44,003		23,943		81,641		78,445
Operating (loss) income	(1,950)		43,995		15,917		36,889
Other expense:
Interest income	12		1		33		2
Interest expense	(481)		(253)		(795)		(591)
Other, net	94		(376)		(26)		(261)
Total other expense, net	(375)		(628)		(788)		(850)
(Loss) income from continuing operations before income taxes	(2,325)		43,367		15,129		36,039
Income tax expense	2,242		9,398		5,680		7,056
(Loss) income from continuing operations	(4,567)		33,969		9,449		28,983
Discontinued operations:
Income (loss) from discontinued operations before income taxes	49		(34)		(77)		(63)
Income tax expense of discontinued operations	84		97		90		192
Loss from discontinued operations	(35)		(131)		(167)		(255)
Net (loss) income	$	(4,602)	$	33,838	$	9,282	$	28,728

Basic (loss) income per share from continuing operations	$	(0.15)	$	1.13	$	0.31	$	0.97
Basic loss per share from discontinued operations	—		—		(0.01)		(0.01)
Basic net (loss) income per share	$	(0.15)	$	1.13	$	0.30	$	0.96

Diluted (loss) income per share from continuing operations	$	(0.15)	$	1.05	$	0.29	$	0.90
Diluted loss per share from discontinued operations	—		(0.01)		—		—
Diluted net (loss) income per share	$	(0.15)	$	1.04	$	0.29	$	0.90

Shares used in per share calculations:
Basic	30,968		30,038		30,833		29,974
Diluted	30,968		32,401		32,437		32,038

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Unaudited and in thousands)


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Net (loss) income	$	(4,602)	$	33,838	$	9,282	$	28,728
Other comprehensive income:
Unrealized loss on available-for-sale securities, net of income tax expense of $7, $—, $— and $—	(4)		—		(4)		—

Foreign currency translation, net of income tax (expense) benefit of $(21), $(13), $(8) and $2	(411)		217		(194)		570
Other comprehensive (loss) income	(415)		217		(198)		570
Comprehensive (loss) income	$	(5,017)	$	34,055	$	9,084	$	29,298

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(Unaudited and in thousands)


	Common Stock			Retained Earnings		Accumulated Other Comprehensive Income		Total Shareholders' Equity
	Shares	Amount









Balances at March 31, 2021	30,576	$	2,176	$	180,524	$	(155)	$	182,545
Net income	—	—		13,884		—		13,884
Unrealized loss on marketable securities, net of income tax benefit of $7	—	—		—		—		—

Foreign currency translation adjustment, net of income tax benefit of $13	—	—		—		217		217
Stock-based compensation expense	—	1,225		—		—		1,225
Common stock issued under equity compensation plan, net of shares withheld for tax payments	201	(1,259)		—		—		(1,259)
Common stock issued under employee stock purchase plan	17	269		—		—		269

Balances at June 30, 2021	30,794	2,411		194,408		62		196,881
Net loss	—	—		(4,602)		—		(4,602)
Unrealized loss on marketable securities, net of income tax expense of $7	—	—		—		(4)		(4)

Foreign currency translation adjustment, net of income tax benefit of $21	—	—		—		(411)		(411)
Stock-based compensation expense	—	1,540		—		—		1,540
Common stock issued under equity compensation plan, net of shares withheld for tax payments	365	(893)		—		—		(893)


Balances at September 30, 2021	31,159	$	3,058	$	189,806	$	(353)	$	192,511


	Common Stock			Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders' Equity
	Shares	Amount









Balances at March 31, 2020	29,817	$	1,781	$	92,456	$	(1,312)	$	92,925
Net loss	—	—		(5,110)		—		(5,110)


Foreign currency translation adjustment, net of income tax benefit of $15	—	—		—		353		353
Stock-based compensation expense	—	865		—		—		865
Common stock issued under equity compensation plan, net of shares withheld for tax payments	87	—		—		—		—
Common stock issued under employee stock purchase plan	63	83		—		—		83

Balances at June 30, 2020	29,967	2,729		87,346		(959)		89,116
Net income	—	—		33,838		—		33,838


Foreign currency translation adjustment, net of income tax expense of $13	—	—		—		217		217
Stock-based compensation expense	—	1,071		—		—		1,071
Common stock issued under equity compensation plan, net of shares withheld for tax payments	290	(796)		—		—		(796)


Balances at September 30, 2020	30,257	$	3,004	$	121,184	$	(742)	$	123,446

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)


	Six-Months Ended September 30,
	2021		2020
Cash flows from operating activities:
Income from continuing operations	$	9,449	$	28,983
Loss from discontinued operations	(167)		(255)
Net income	9,282		28,728
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	3,979		4,497
(Benefit) provision for allowance for doubtful accounts	(179)		612
Inventory lower of cost or net realizable value	—		1,137
Stock-based compensation expense	2,765		1,936
Loss on asset dispositions	—		980

Loss on disposal group, goodwill and other intangible impairment charge	—		20,668
Deferred income taxes, net of valuation allowances	(1,336)		(4,885)

Other	1,361		(1,740)
Changes in operating assets and liabilities:
Trade receivables	213		(39,373)
Inventories	(94,107)		(10,347)
Prepaids and other assets	7,256		(868)
Income taxes receivable	(8,080)		3,549
Trade payables	16,182		52,595
Accrued liabilities and other liabilities, including warranty obligations	5,910		6,117
Net cash (used in) provided by operating activities	(56,754)		63,606
Cash flows from investing activities:

Proceeds from sales and maturities of available-for-sale securities	73,448		—

Acquisition of business, net of cash acquired	(26,759)		—
Purchases of property, plant and equipment	(4,985)		(6,268)


Net cash provided by (used in) investing activities	41,704		(6,268)
Cash flows from financing activities:
Proceeds from long-term debt	7,025		1,143
Payments on long-term debt	(3,556)		(13,566)




Proceeds from employee stock purchases	269		83
Proceeds from exercise of stock options	470		47
Tax payments related to stock award issuances	(2,623)		(843)

Net cash provided by (used in) financing activities	1,585		(13,136)
Effect of exchange rate changes	(910)		1,719
(Decrease) increase in cash, cash equivalents and restricted cash	(14,375)		45,921
Less: Net change in cash balances classified as assets held-for-sale	—		(108)
Net change in cash, cash equivalents and restricted cash	(14,375)		45,813
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash at beginning of period	39,780		26,456
Cash, cash equivalents and restricted cash at end of period	$	25,405	$	72,269

Supplemental disclosure of cash flow information:
Cash paid for interest	$	323	$	466
Cash paid for income taxes, net	19,960		8,462
Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	$	1,052	$	989

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:
	September 30,
	2021		2020
Cash and cash equivalents	$	20,179	$	70,072
Restricted cash	1,339		2,197
Other assets - restricted, non-current	3,887		—
Total cash, cash equivalents and restricted cash	$	25,405	$	72,269

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) GENERAL INFORMATION

Basis of Consolidation and Presentation

The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.

On December 30, 2020, our Board of Directors approved a change in our fiscal year end from December 31st to March 31st. This document reflects our second fiscal quarter, which ended September 30, 2021, of our fiscal year from April 1, 2021 through March 31, 2022.

The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”).

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Uncertainties regarding such estimates and assumptions are inherent in the preparation of financial statements and actual results could differ from those estimates. These uncertainties will be heightened by the COVID-19 pandemic, as we may be unable to accurately predict the impact of COVID-19 going forward and as a result our estimates may change in the near term. Further information regarding significant estimates can be found in our 2020 Form 10-K. We have reclassified certain amounts in prior-period financial statements to conform to the current period's presentation. On the consolidated balance sheets, we have reclassified from accrued liabilities to income taxes payable, current portion.

In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of September 30, 2021 and March 31, 2021, and our results of operations, comprehensive income and shareholders' equity for the three and six-month periods ended September 30, 2021 and 2020 and our cash flows for the six-month periods ended September 30, 2021 and 2020. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally, and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.

Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.

Updates to Significant Accounting Policies

Goodwill

Goodwill consists of the excess of acquisition costs over the fair values of net assets acquired in business combinations. We review goodwill for impairment in the fourth quarter of each year and when events or changes in circumstances indicate that the carrying amount may be impaired. For this purpose, goodwill is evaluated at the reporting unit level. For further information regarding goodwill, see Note 8, Goodwill and Other intangible assets.

Recent Accounting Pronouncements

Recently Adopted Pronouncements

ASU 2019-12

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” The amendments in ASU 2019-12 introduce the following new guidance: (1) provides a policy

Table of Contents

election to not allocate consolidated income taxes when a member of a consolidated tax return is not subject to income tax; and (2) provides guidance to evaluate whether a step-up in tax basis of goodwill relates to a business combination in which book goodwill was recognized or a separate transaction. The amendments in ASU 2019-12 make changes to the following current guidance: (1) making an intra-period allocation if there is a loss in continuing operations and a gain outside of continuing operations; (2) determining when a deferred tax liability is recognized after an investor in a foreign entity transitions to or from the equity method of accounting; (3) accounting for tax law changes and year-to-date losses in interim periods; and (4) determining how to apply the income tax guidance to franchise taxes that are partially based on income. ASU 2019-12 is effective for public business entities' fiscal years, including interim periods within those fiscal years, beginning after December 15, 2020 with early adoption permitted. Our adoption of ASU 2019-12 as of January 1, 2021 had no material impact on our financial position, results of operations or cash flows.

Recently Issued Pronouncements Not Yet Adopted

ASU 2020-04 and ASU 2021-01

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848),” which provides optional guidance related to reference rate reform and provides practical expedients for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. This guidance is applicable for our borrowing instruments, which use London Inter-bank Offered Rate (“LIBOR”) as a reference rate, which is effective beginning on March 12, 2020, and we may elect to apply the amendments prospectively through December 31, 2022. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. We do not expect the adoption of this guidance to have a material impact on our financial position, results of operations and cash flows.

ASU 2020-01

In January 2020, the FASB issued ASU 2020-01, “Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. These amendments improve current GAAP by reducing diversity in practice and increasing comparability of the accounting for these interactions. ASU 2020-01 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We do not expect the adoption of this guidance would have a material impact on our financial position, results of operations and cash flows.

ASU 2016-13

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In May 2019, the FASB issued ASU 2019-05, which provides entities to have certain instruments with an option to irrevocably elect the fair value option. In November 2019, the FASB issued ASU 2019-11, which provides clarification and addresses specific issues about certain aspects of ASU 2016-13. In March 2020, the FASB issued ASC 2020-03, which provides an update to clarify or address specific issues. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those years. We do not expect the adoption of this guidance would have a material impact on our financial position, results of operations and cash flows.

Table of Contents

(2) BUSINESS ACQUISITION

On September 17, 2021, we acquired VAY AG (“VAY”) for an aggregate purchase consideration of approximately $27.0 million using cash on hand. Headquartered in Zurich, Switzerland, VAY specializes in computer vision and AI technology solutions and has developed software solutions for human motion analysis using any normal RGB (red-green-blue) camera from a device, such as a laptop, smartphone, or tablet. With a mission to democratize professional human motion analysis, VAY enables clients in fitness and health industries to understand and analyze human movement, providing personalized feedback on repetitions and form in real-time.

We accounted for the transaction as a business combination. Goodwill from the acquisition of $24.5 million represents the excess of the purchase price over the fair value of the net tangible and intangible assets and liabilities assumed and is not deductible for tax purposes. Goodwill recorded in connection with this acquisition is primarily attributable to intellectual property base, employee workforce and application to future digital technologies.

Total acquisition costs incurred through the three-months and six months ended September 30, 2021 were $0.8 million and $1.0 million, respectively, and were expensed in general and administrative costs. Since the acquisition occurred on September 17, 2021, no material amount of net sales or net income related to the VAY business was included in our reported September 30, 2021 financial statements.

The sellers of VAY have the opportunity to earn additional contingency consideration subject to the achievement of continued employment over an 18 month period and a total of twenty software engineers. The contingent consideration arrangement requires the Company to pay the former owners of VAY upon achievement of these milestones $3.9 million and will be recognized as compensatory expense over the service period. An escrow account was funded for the contingency consideration and is reported as Other assets - restricted, non-current.

Purchase Price Allocation

Acquired assets were recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair value of identifiable net assets resulted in the recognition of goodwill of $24.5 million, and is attributed primarily to VAY intellectual property base, employee workforce and application to future digital technologies. The goodwill is not deductible for income tax purposes. Certain liabilities were acquired as part of the transaction.

The purchase price allocation was determined based on the preliminary fair values of the assets identified as of the acquisition date. It may be adjusted, within a period of no more than 12 months from the acquisition date, if the preliminary fair values change as a result of circumstances existing at the acquisition date, and upon receipt of final appraisals and valuations. Such fair value adjustments may arise in respect of property, plant and equipment upon completion of the necessary valuations and physical verifications of such assets.

As of September 30, 2021, the fair values of the assets acquired are preliminary because final appraisals and valuations have not yet been completed. The following table summarizes the preliminary fair values of the assets acquired as of the acquisition date (in thousands):

Table of Contents


	Preliminary Valuation at September 17, 2021
Cash	$	230
Accounts receivable	9

Prepaid expenses	15
Deferred tax assets	58
Developed technology (included in property, plant and equipment)	3,000

Identifiable assets acquired	3,312


Accrued liabilities	187
Unearned revenue	53
Deferred tax liabilities, non-current	591

Total liabilities assumed	831

Net identifiable assets acquired	2,481
Goodwill	24,508
Total assets acquired	$	26,989

This acquisition is not material to our net sales, results of operations or total assets during any period presented. Accordingly, our consolidated results from operations do not differ materially from historical performance as a result of this acquisition, and, therefore, pro forma results are not presented.

(3) REVENUES

Our revenues from contracts with customers disaggregated by revenue source, excluding sales-based taxes, were as follows (in thousands):


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Product sales	$	133,126	$	150,639	$	312,937	$	261,234
Extended warranties and services	1,388		1,905		3,144		3,370
Other(1)	3,445		2,847		6,471		4,975
Net sales	$	137,959	$	155,391	$	322,552	$	269,579

(1) Other revenue is primarily freight and delivery, royalty income and subscription revenue.

Our revenues disaggregated by geographic region, based on ship-to address, were as follows (in thousands):


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
United States	$	102,521	$	130,289	$	249,670	$	227,652
Canada	17,852		12,744		37,214		18,992
Europe, the Middle East and Africa	13,140		8,505		27,582		16,998
All other	4,446		3,853		8,086		5,937
Net sales	$	137,959	$	155,391	$	322,552	$	269,579

Table of Contents

As of September 30, 2021, estimated revenue expected to be recognized in the future totaled $84.0 million, primarily related to customer order backlog, which includes firm orders for future shipment and unfulfilled orders to our Retail customers, as well as unfulfilled consumer orders within the Direct channel. We have further refined our Retail backlog to include unfilled future orders. Direct orders of $1.1 million and Retail orders of $82.9 million comprised our backlog as of September 30, 2021, compared to Direct orders of $23.1 million and Retail orders of $208.5 million as of September 30, 2020. The estimated future revenues are net of contractual rebates and consideration payable for applicable Retail customers, and net of current promotional programs and sales discounts for our Direct customers. Due to the severe shortage of shipping containers, some factory fulfilled orders, representing over $22 million in revenue, did not ship as planned in late September. 56% of those orders shipped in October.

The following table provides information about our liabilities from contracts with customers, primarily customer deposits and deferred revenue for which advance consideration is received prior to the transfer of control. Revenue is recognized when transfer of control occurs. All customer deposits and deferred revenue received are short-term in nature and were recorded on the condensed consolidated balance sheets as accrued liabilities. Significant changes in contract liabilities balances, including revenue recognized in the reporting period that was included in opening contract liabilities, are shown below (in thousands):


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Balance, beginning of period	$	1,757	$	3,503	$	5,551	$	2,050
Cash additions	3,457		1,182		4,546		3,553
Revenue recognition	(1,761)		(1,046)		(6,644)		(1,964)
Balance, end of period	$	3,453	$	3,639	$	3,453	$	3,639

(4) FAIR VALUE MEASUREMENTS

Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:

•Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;

•Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk, or observable market prices in markets with insufficient volume and/or infrequent transactions; and

•Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.

Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):


	September 30, 2021
	Level 1		Level 2		Level 3		Total
Assets:













Derivatives

Foreign currency forward contracts	—		126		—		126
Total derivatives	—		126		—		126
Total assets measured at fair value	$	—	$	126	$	—	$	126

Table of Contents


	March 31, 2021
	Level 1		Level 2		Level 3		Total
Assets:
Cash Equivalents
Money market funds	$	9,679	$	—	$	—	$	9,679




Total cash equivalents	9,679		—		—		9,679
Available-for-Sale Securities

Commercial paper	—		9,994		—		9,994
Corporate bonds	—		8,227		—		8,227
U.S. government bonds	—		55,227		—		55,227
Total available-for-sale securities	—		73,448		—		73,448




Total assets measured at fair value	$	9,679	$	73,448	$	—	$	83,127

Liabilities:
Derivatives

Foreign currency forward contracts	$	—	$	672	$	—	$	672
Total liabilities measured at fair value	$	—	$	672	$	—	$	672

For our assets measured at fair value on a recurring basis, we recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer. There were no transfers between levels during the six-month period ended September 30, 2021, nor for the year ended March 31, 2021.

We classify our marketable securities as available-for-sale and, accordingly, record them at fair value. Level 1 investment valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 investment valuations are obtained from inputs, other than quoted market prices in active markets for identical assets, that are directly or indirectly observable in the marketplace and quoted prices in markets with limited volume or infrequent transactions. The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in comprehensive income until realized.

The fair values of our foreign currency forward contracts are calculated as the present value of estimated future cash flows using discount factors derived from relevant Level 2 market inputs, including forward curves and volatility levels.

We did not have any changes to our valuation techniques during the during the six-month period ended September 30, 2021, nor for the year ended March 31, 2021.

We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily property, plant and equipment, goodwill, other intangible assets and certain other long-lived assets in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. Other than assets acquired, see Note 2, Business Acquisition, we determined the fair value of our developed technology included in property, plant and equipment using the cost approach which considers how much it would cost to replace an asset of equivalent utility. We did not perform any valuations on assets or liabilities that are valued at fair value on a nonrecurring basis. We perform our goodwill and indefinite-lived trade names impairment valuations annually or when triggering events are identified.

As of September 30, 2021 and March 31, 2021, there were no assets or liabilities that were recorded at fair value on a nonrecurring basis.

The carrying values of cash and cash equivalents, restricted cash, trade receivables, prepaids and other current assets, trade payables and accrued liabilities approximate fair value due to their short maturities. The carrying value of our debt approximates its fair value and falls under Level 2 of the fair value hierarchy, as the interest rate is variable and based on current market rates.

Table of Contents

(5) DERIVATIVES

From time to time, we enter into foreign exchange forward contracts to offset the earnings impacts of exchange rate fluctuations on certain monetary assets and liabilities. We do not enter into derivative instruments for any purpose other than to manage foreign currency exposure. That is, we do not engage in currency exchange rate speculation using derivative instruments.

We may hedge our net recognized foreign currency assets and liabilities with forward foreign exchange contracts to reduce the risk that our earnings and cash flows will be adversely affected by changes in foreign currency exchange rates. These derivative instruments hedge assets and liabilities that are denominated in foreign currencies and are carried at fair value with changes in the fair value recorded as other income. These derivative instruments do not subject us to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged. As of September 30, 2021, total outstanding contract notional amounts were $42.3 million and had maturities of 78 days or less.

The fair value of our derivative instruments was included in our condensed consolidated balance sheets as follows (in thousands):


	Balance Sheet Classification	As of
		September 30, 2021		March 31, 2021




Derivative instruments not designated as cash flow hedges:
Foreign currency forward contracts	Prepaids and other current assets	$	126	$	—
	Accrued liabilities	—		672

The effect of derivative instruments on our condensed consolidated statements of operations was as follows (in thousands):


	Statement of Operations Classification	Three-Months Ended September 30,				Six-Months Ended September 30,
		2021		2020		2021		2020





Derivative instruments not designated as cash flow hedges:
Loss recognized in earnings	Other, net	$	(943)	$	(284)	$	(960)	$	(425)
Income tax benefit	Income tax expense	238		71		234		106

(6) INVENTORIES

Inventories are stated at the lower of cost and net realizable value, with cost determined based on the first-in, first-out method. Our inventories consisted of the following (in thousands):


	As of
	September 30, 2021		March 31, 2021
Finished goods (1)	$	155,962	$	63,918
Parts and components	6,707		4,167
Total inventories	$	162,669	$	68,085

(1) Finished goods increase was driven by the strategic decision to increase on-hand inventory levels ahead of the fitness season given continued disruption in global logistics.

Table of Contents

(7) PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):


	Estimated Useful Life (in years)			As of
				September 30, 2021		March 31, 2021
Automobiles	5			$	23	$	23
Leasehold improvements	4	to	20	3,149		3,059
Computer software and equipment	2	to	7	41,112		36,956
Machinery and equipment	3	to	5	15,861		15,699
Furniture and fixtures	5	to	20	2,635		2,586
Work in progress(1)	N/A			5,438		1,314
Total cost				68,218		59,637
Accumulated depreciation				(38,755)		(35,141)
Total property, plant and equipment, net				$	29,463	$	24,496

(1) Work in progress includes information technology assets and production tooling.

Depreciation expense was as follows (in thousands):


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Depreciation expense	$	1,909	$	1,815	$	3,948	$	3,658

(8) GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The roll forward of goodwill was as follows (in thousands):


	Total
Balance, April 1, 2021	$	—
Business acquisition (Note 2)	24,508

Balance, September 30, 2021	$	24,508

Other Intangible Assets

Other intangible assets consisted of the following (in thousands):


	Estimated Useful Life (in years)			As of
				September 30, 2021		March 31, 2021
Indefinite-lived trademarks	N/A			$	9,052	$	9,052

Patents	7	to	24	1,443		1,443

				10,495		10,495
Accumulated amortization - definite-lived intangible assets				(1,161)		(1,130)
Other intangible assets, net				$	9,334	$	9,365

Amortization expense was as follows (in thousands):


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Amortization expense	$	16	$	38	$	31	$	841

Table of Contents

Future amortization of definite-lived intangible assets is as follows (in thousands):


2022	$	31
2023	61
2024	61
2025	61
2026	47
Thereafter	21
	$	282

(9) LEASES

We have several non-cancellable operating leases, primarily for office space, that expire at various dates over the next nine years. These leases generally contain renewal options to extend for one lease term of five years. For leases that we are reasonably certain we will exercise the lease renewal options, the options were considered in determining the lease term, and associated potential option payments are included in the lease payments. The payments used in the renewal term were estimated using the percentage rate increase of historical rent payments for each location where the renewal will be exercised.

Payments due under the lease contracts include annual fixed payments for office space. Variable payments including payments for our proportionate share of the building’s property taxes, insurance, and common area maintenance are treated as non-lease components and are recognized in the period for which the costs occur.

Operating lease expense was as follows (in thousands):


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Operating lease expense	$	1,466	$	1,052	$	2,932	$	2,197

Leases with an initial term of 12 months or less (“short-term lease”) are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term.

Other information related to leases was as follows (dollars in thousands):


	As of
	September 30, 2021		March 31, 2021
Supplemental cash flow information:
Cash paid for amounts included in the measurement of operating lease liabilities:
Operating cash flow from operating leases	$	1,497	$	1,076
Additional operating lease information:

Reductions to ROU assets resulting from reductions to operating lease obligations	$	343	$	268

Weighted average remaining operating lease term (years)	6.07		6.97
Weighted average discount rate on operating leases	5.01%		4.95%

We determined the discount rate for leases using a portfolio approach to determine an incremental borrowing rate to calculate the right-of-use assets and lease liabilities.

Maturities of operating lease liabilities under non-cancellable leases were as follows (in thousands):

Table of Contents


	As of
	September 30, 2021
2022	$	3,005
2023	5,606
2024	5,168
2025	5,330
2026	4,267
Thereafter	7,967
Total undiscounted lease payments	31,343
Less imputed interest	(4,571)
Total lease liabilities	$	26,772

(10) ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):


	As of
	September 30, 2021		March 31, 2021
Payroll and related liabilities	$	7,420	$	6,616
Reserves (1)	3,081		2,624
Deferred revenue	3,453		5,551
Legal settlement (2)	4,250		—
Other	4,198		4,836
Total accrued liabilities	$	22,402	$	19,627

(1) Reserves is primarily sales return, inventory, sales tax and product liability reserves.

(2) Legal settlement is a loss contingency accrual related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. For further information, see Note 16, Commitments and Contingencies.

(11) PRODUCT WARRANTIES

Our products carry defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in cost of sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.

Changes in our product warranty obligations were as follows (in thousands):


	Six-Months Ended September 30,
	2021		2020
Balance, beginning of period	$	9,782	$	6,250
Accruals (1)	(551)		(487)

Payments	(1,865)		(2,238)
Balance, end of period	$	7,366	$	3,525

(1) Accruals were negative for the six-months ended September 30, 2021 due to a reversal of a special warranty reserve related to indoor cycling bikes and for the six-months ended September 30, 2020 due to assets held for sale.

Table of Contents

(12) ACCUMULATED OTHER COMPREHENSIVE LOSS

The following tables set forth the changes in accumulated other comprehensive loss, net of tax (in thousands):


	Unrealized (Loss) Income on Available-for-Sale Securities		Gain on Derivative Securities		Foreign Currency Translation Adjustments		Accumulated Other Comprehensive Loss
Balance, March 31, 2021	$	(8)	$	—	$	(147)	$	(155)
Current period other comprehensive income (loss) before reclassifications	(4)		—		(194)		(198)

Net other comprehensive income (loss) during period	(4)		—		(194)		(198)
Balance, September 30, 2021	$	(12)	$	—	$	(341)	$	(353)



	Unrealized (Loss) Gain on Available-for-Sale Securities		Gain on Derivative Securities		Foreign Currency Translation Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance, June 30, 2021	$	(8)	$	—	$	70	$	62
Current period other comprehensive income (loss) before reclassifications	(4)		—		(411)		(415)

Net other comprehensive income (loss) during period	(4)		—		(411)		(415)
Balance, September 30, 2021	$	(12)	$	—	$	(341)	$	(353)



	Unrealized Gain on Available-for-Sale Securities		Gain on Derivative Securities		Foreign Currency Translation Adjustments		Accumulated Other Comprehensive Loss (Income)
Balance, March 31, 2020	$	—	$	—	$	(1,312)	$	(1,312)
Current period other comprehensive income before reclassifications	—		—		570		570

Net other comprehensive income during period	—		—		570		570
Balance, September 30, 2020	$	—	$	—	$	(742)	$	(742)



	Unrealized Gain on Available-for-Sale Securities		Gain on Derivative Securities		Foreign Currency Translation Adjustments		Accumulated Other Comprehensive (Loss) Income
Balance, June 30, 2020	$	—	$	—	$	(959)	$	(959)
Current period other comprehensive income before reclassifications	—		—		217		217

Net other comprehensive income during period	—		—		217		217
Balance, September 30, 2020	$	—	$	—	$	(742)	$	(742)

Table of Contents

(13) (LOSS) INCOME PER SHARE

Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. Basic income per share amounts were computed using the weighted average number of common shares outstanding. Diluted income per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method.

The weighted average numbers of shares outstanding used to compute (loss) income per share were as follows (in thousands):


	Three-Months Ended September 30,		Six-Months Ended September 30,
	2021	2020	2021	2020
Shares used to calculate basic income per share	30,968	30,038	30,833	29,974
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	—	2,363	1,604	2,064
Shares used to calculate diluted income per share	30,968	32,401	32,437	32,038

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted per share due to loss from continuing operations, as such, the exercise or conversion of any potential shares would increase the number of shares in the denominator and result in a lower loss per share (in thousands):


	Three-Months Ended September 30,		Six-Months Ended September 30,
	2021	2020	2021	2020

Restricted stock units	894	—	—	—
Stock options	526	—	—	—

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share. In the case of restricted stock units, this is because unrecognized compensation expense exceeds the current value of the awards (i.e., grant date market value was higher than current average market price). In the case of stock options, this is because the average market price did not exceed the exercise price.

These shares may be anti-dilutive potential common shares in the future (in thousands):


	Three-Months Ended September 30,		Six-Months Ended September 30,
	2021	2020	2021	2021

Restricted stock units	407	1	295	2
Stock options	2	4	2	14

(14) SEGMENT AND ENTERPRISE-WIDE INFORMATION

We have two operating segments, Direct and Retail. There were no changes in our operating segments during the six-months ended September 30, 2021.

We evaluate performance of the operating segments using several factors, of which the primary financial measures are net sales and reportable segment contribution. Contribution is the measure of profit or loss, defined as net sales less product costs and directly attributable expenses. Directly attributable expenses include selling and marketing expenses, general and administrative expenses, and research and development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily accounts receivable, inventories and other intangible assets. Unallocated assets primarily include cash, cash equivalents and restricted cash, derivative securities, shared information technology infrastructure, distribution

Table of Contents

centers, corporate headquarters, prepaids and other current assets, deferred income tax assets and other assets. Capital expenditures directly attributable to the Direct and Retail segments were not significant in any period.

Following is summary information by reportable segment (in thousands):


	Three-Months Ended September 30,				Six-Months Ended September 30,
	2021		2020		2021		2020
Net sales:
Direct	$	37,853	$	61,194	$	101,249	$	111,627
Retail	99,153		93,155		219,637		156,103
Royalty	953		1,042		1,666		1,849
Consolidated net sales	$	137,959	$	155,391	$	322,552	$	269,579

Contribution:
Direct	$	(1,835)	$	17,588	$	4,924	$	34,583
Retail	18,741		23,442		40,831		35,055
Royalty	953		1,042		1,666		1,849
Consolidated contribution	$	17,859	$	42,072	$	47,421	$	71,487

Reconciliation of consolidated contribution to (loss) income from continuing operations:
Consolidated contribution	$	17,859	$	42,072	$	47,421	$	71,487
Amounts not directly related to segments:
Operating expenses	(19,809)		1,923		(31,504)		(34,598)
Other expense, net	(375)		(628)		(788)		(850)
Income tax expense	(2,242)		(9,398)		(5,680)		(7,056)
(Loss) income from continuing operations	$	(4,567)	$	33,969	$	9,449	$	28,983


	As of
	September 30, 2021		March 31, 2021
Assets:
Direct	$	64,780	$	47,002
Retail	211,566		146,001
Unallocated corporate	114,684		161,227
Total assets	$	391,030	$	354,230

The following customers accounted for 10% or more of total net sales as follows:


	Three-Months Ended September 30,		Six-Months Ended September 30,
	2021	2020	2021	2020
Best Buy	18.6%	*	17.8%	*
Amazon.com	15.4%	22.9%	16.8%	20.8%



*Less than 10% of total net sales.

Table of Contents

(15) BORROWINGS

Wells Fargo Bank Credit Agreement

On May 13, 2021, we amended our Credit Agreement, dated January 31, 2020, with Wells Fargo Bank, National Association (“Wells Fargo”) and lenders from time to time party thereto (collectively with Wells Fargo the “Lenders”) (the “Credit Agreement”), pursuant to which the Lenders have agreed, among other things, to make available to us an asset-based revolving loan facility in the aggregate principal amount of up to $55.0 million, subject to a borrowing base (the “ABL Revolving Facility”), and a term loan facility in the aggregate principal amount of $15.0 million (the “Term Loan Facility” and together with the ABL Revolving Facility, the “Credit Facility”), in each case, as such amounts may increase or decrease in accordance with the terms of the Credit Agreement. Several key features have been beneficially amended including permanently removing the $7.5 million minimum liquidity covenant and minimum EBITDA covenant that was scheduled to commence on February 1, 2022. The Credit Facility now contains a single market-based 1.0x springing fixed charge coverage ratio tested only when availability is less than the greater of $6.0 million and 12.5% of the Loan Cap, as defined in the Credit Agreement. Various borrowing base definitions and limits were also amended that will result in improved availability under the ABL Revolving Facility. In addition to the above structural improvements, the interest rate on the Term Loan Facility was reduced to LIBOR plus 4.50% versus 5.00%.The Term Loan Facility continues to contain amortization as originally scheduled. The repayment of obligations under the Credit Agreement is secured by substantially all of our assets. Principal and interest amounts are required to be paid as scheduled.

Interest on the ABL Revolving Facility will accrue at LIBOR plus a margin of 1.75% to 2.25% (based on average quarterly availability) and interest on the Term Loan Facility will accrue at LIBOR plus 4.50%. As of September 30, 2021, our interest rate was 1.83% for the ABL Revolving Facility and 4.58% for the Term Loan Facility.

As of September 30, 2021, outstanding borrowings totaled $17.5 million, with $11.5 million and $6.0 million under our Term Loan Facility and ABL Revolving Facility, respectively. As of September 30, 2021, we were in compliance with the financial covenants of the Credit Agreement and $49.0 million was available for borrowing under the ABL Revolving Facility. Any outstanding balance is due and payable on January 31, 2025.

The balance sheet classification of the borrowings under the revolving loan credit facility has been determined in accordance with ASC 470, Debt. Borrowings outstanding under a revolving credit agreement that includes both a subjective acceleration clause and a requirement to maintain a springing lock-box arrangement are classified based on the provisions of ASC 470 because the lock-box remittances do not automatically reduce the debt outstanding.

See Note 17 for a discussion of an amendment to the Credit Agreement in October 2021, which included extending the maturity date from January 31, 2025 to October 29, 2026.

(16) COMMITMENTS AND CONTINGENCIES

Guarantees, Commitments and Off-Balance Sheet Arrangements

As of September 30, 2021, we had standby letters of credit of $0.9 million.

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of September 30, 2021, we had approximately $78.0 million compared to $216.3 million as of March 31, 2021 in non-cancellable market-based purchase obligations, primarily to secure additional factory capacity for inventory purchases in the next twelve months. The decrease in purchase obligations was primarily due to having received much of the inventory we have ordered for the season. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

Table of Contents

The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows, and therefore, no related liabilities were recorded as of September 30, 2021.

Legal Matters

We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, the current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties. Further, while we face contingencies that are reasonably possible to occur, other than as discussed below, we are unable to estimate the possible loss or range of loss at this time.

As of September 30, 2021, we accrued $4.7 million for a loss contingency related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. The settlement includes damages, a one-year free membership to JRNY®, and administrative fees and is reflected in Accrued liabilities and Other long-term liabilities on the face of our Consolidated Balance Sheet and reported as general and administrative expenses.

(17) SUBSEQUENT EVENTS

On October 29, 2021, we amended our Credit Agreement. The amendment increased the aggregate principal amount available under the ABL Revolving Facility from $55.0 million to $100.0 million (“Revolver”), subject to a borrowing base. The maturity date of the Credit Facility was extended to October 29, 2026. The unamortized balance on the Term Loan was $11.5 million, as of the effective date of the Amendment, and will amortize on a new 60-month straight line basis to coincide with the extended maturity date.

Other structural improvements to the Credit Agreement include amending the definition of Springing Trigger Event to mean the greater of (i) 10.0% of the lesser of (a) the Revolver Commitment and (b) the Borrowing Base as of such date of determination and (ii) $7.5 million. The Springing Trigger Event pertains to the period in which a Fixed Charge Coverage Ratio test will apply and be tested. Consistent with the Credit Agreement before the Amendment, there continues to be no additional financial maintenance covenants. Additionally, the borrowing base definitions were favorably amended to change the eligible in-transit inventory sublimit from $10.0 million to $22.5 million and the total inventory sublimit from $35.0 million to $65.0 million.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is based upon our financial statements as of the dates and for the periods presented in this section. You should read this discussion and analysis in conjunction with the financial statements and notes thereto found in Part I, Item 1 of this Form 10-Q and our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”). All references to the second quarter of 2021 and 2020 mean the three and six-month periods ended September 30, 2021 and 2020, respectively. Unless the context otherwise requires, “Nautilus,” “we,” “us” and “our” refer to Nautilus, Inc. and its subsidiaries. Unless indicated otherwise, all information regarding our operating results pertains to our continuing operations.

Cautionary Notice About Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plan,” “expect,” “aim,” “believe,” “project,” “intend,” “estimate,” “will,” “should,” “could,” and other terms of similar meaning typically identify forward-looking statements. We also may make forward-looking statements in our other documents filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”). In addition, our senior management may make forward-looking statements orally to analysts, investors, representatives of the media and others. Forward-looking statements include any statements related to our future business, financial performance or operating results; anticipated fluctuations in net sales due to seasonality; plans and expectations regarding gross and operating margins; plans and expectations regarding research and development expenses and capital expenditures and anticipated results from such expenditures and other investments in our capabilities and resources; anticipated losses from discontinued operations; plans for new product introductions, strategic partnerships and anticipated demand for our new and existing products; and statements regarding our inventory and working capital requirements and the sufficiency of our financial resources. These forward-looking statements, and others we make from time-to-time, are subject to a number of risks and uncertainties. Many factors could cause actual results to differ materially from those projected in forward-looking statements, including our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs, changes in consumer fitness trends, changes in the media consumption habits of our target consumers or the effectiveness, availability and price of media time consistent with our cost and audience profile parameters, greater than anticipated costs or delays associated with launch of new products, weaker than expected demand for new or existing products, a decline in consumer spending due to unfavorable economic conditions, softness in the retail marketplace or the availability from retailers of heavily discounted competitive products, an adverse change in the availability of credit for our customers who finance their purchases, our ability to pass along vendor raw material price increases and other cost pressures, including increased shipping costs and unfavorable foreign currency exchange rates, tariffs, risks associated with current and potential delays, work stoppages, or supply chain disruptions caused by the coronavirus pandemic, our ability to hire and retain key management personnel, our ability to effectively develop, market and sell future products, the availability and timing of capital for financing our strategic initiatives, including being able to raise capital on favorable terms or at all; changes in the financial markets, including changes in credit markets and interest rates that affect our ability to access those markets on favorable terms, the impact of any future impairments, our ability to protect our intellectual property, the introduction of competing products, and our ability to get foreign-sourced product through customs in a timely manner. Additional assumptions, risks and uncertainties are described in Part I, Item 1A, “Risk Factors,” in our 2020 Form 10-K as supplemented or modified in our quarterly reports on Form 10-Q. We do not undertake any duty to update forward-looking statements after the date they are made or conform them to actual results or to changes in circumstances or expectations.

Overview

We empower healthier living through individualized connected fitness experiences and are committed to building a healthier world, one person at a time. Our principal business activities include designing, developing, sourcing and marketing high-quality cardio and strength fitness products, related accessories and digital platform for consumer use, primarily in the U.S., Canada, Europe and Asia. Our products are sold under some of the most-recognized brand names in the fitness industry: Bowflex®, Schwinn®, JRNY® and Nautilus®.

We market our products through two distinct distribution channels, Direct and Retail, which we consider to be separate business segments. Our Direct business offers products directly to consumers primarily through websites. Our Retail business offers our products through a network of independent retail companies to reach consumers in the home use markets in the U.S. and internationally. We also derive a portion of our revenue from the licensing of our brands and intellectual property.

Table of Contents

As previously disclosed, we changed our fiscal year from the twelve months beginning January 1 and ending December 31 to the twelve months beginning April 1 and ending March 31.

Our results for the three and six-months ended September 30, 2021, are driven by the actions outlined in our North Star strategy. The five strategic pillars of our North Star strategy are: (1) Adopt a consumer first mindset; (2) Scale a differentiated digital offering; (3) Focus investments on core businesses; (4) Evolve supply chain to be a strategic advantage; and (5) Build organizational capabilities to win by unleashing the power of our team. We intend to leverage our many strengths to transform into a company that empowers healthier living through individualized connected fitness experiences. Our transformation will properly leverage our leading brands, products, innovation, distribution and digital assets to build a healthier world, one person at a time.

Comparison for the Three-Months Ended September 30, 2021 to the Three-Months ended September 30, 2020

•Net sales were $138.0 million for the three-months ended September 30, 2021, compared to $155.4 million a decline of 11.2% versus for the three-months ended September 30, 2020, or down 5.4%, excluding sales related to the Octane brand, which was sold in October 2020. The sales decline was driven primarily by lower Direct sales and shipping constraints. Due to the severe shortage of shipping containers, some factory fulfilled orders, representing over $22 million in revenue, did not ship as planned in late September. 56% of those orders shipped in October.

•Net sales of our Direct segment decreased by $23.3 million, or 38.1%, for the three-months ended September 30, 2021, compared to the three-months ended September 30, 2020.

•Net sales of our Retail segment increased by $6.0 million, or 6.4%, for the three-months ended September 30, 2021, compared to the three-months ended September 30, 2020. Excluding sales related to the Octane brand, which was sold in 2020, net sales grew 18.6%.

•Royalty income for the three-months ended September 30, 2021 decreased by $0.1 million compared to the three-months ended September 30, 2020.

•Gross profit was $42.1 million for the three-months ended September 30, 2021, compared to gross profit of $67.9 million for the three-months ended September 30, 2020. Gross profit margins were 30.5% for the three-months ended September 30, 2021 compared to 43.7% for the three-months ended September 30, 2020. The 13.2 ppt decrease in gross margins was primarily due to: logistics (-8 ppts), commodities, components, and foreign exchange (-4 ppts) and increased investments in JRNY® (-1 ppt).

•Operating expenses were $44.0 million for the three-months ended September 30, 2021, an increase of $20.1 million, or 83.8%, compared to operating expenses of $23.9 million for the three-months ended September 30, 2020, primarily due to the $8.3 million Octane Gain on Disposal Group for the three-months ended September 30, 2020, a legal settlement of $4.7 million, $4.0 million more in advertising, $3.5 million increase in JRNY® investments, and acquisition expenses of $0.8 million. Total advertising expenses were $12.1 million for the three-months ended September 30, 2021 versus $8.0 million for the three-months ended September 30, 2020, trending more towards historical levels.

•Operating loss was $2.0 million or negative 1.4% operating margin for the three-months ended September 30, 2021, compared to an operating income of $44.0 million for the three-months ended September 30, 2020, primarily due to lower gross profits and higher operating expenses.

•Loss from continuing operations was $4.6 million, or -$0.15 per diluted share, for the three-months ended September 30, 2021, compared to income from continuing operations of $34.0 million, or $1.05 per diluted share, for the three-months ended September 30, 2020.

•Net loss was $4.6 million for the three-months ended September 30, 2021, compared to net income of $33.8 million for the three-months ended September 30, 2020.

Table of Contents

•The effective tax rates were negative 96.4% for the three-months ended September 30, 2021 and 21.7% for the three-months ended September 30, 2020, primarily due to the impact of the VAY acquisition.

Comparison for the Six-Months Ended September 30, 2021 to the Six-Months Ended September 30, 2020

•Net sales were $322.6 million up 19.7% for the six-months ended September 30, 2021 compared to net sales of $269.6 million for the six-months ended September 30, 2020. Excluding sales related to the Octane brand, net sales were up 28.2% compared to the six-months ended September 30, 2020. The sales increase was driven primarily by robust sales of our popular SelectTech® weights.

•Gross profit was $97.6 million for the six-months ended September 30, 2021, compared to gross profit of $115.3 million for the six-months ended September 30, 2020. Gross profit margins were 30.2% for the six-months ended September 30, 2021, compared to 42.8% for the six-months ended September 30, 2020. The 12.6 ppts decrease in gross margins was primarily due to: logistics (-7 ppts), commodities, components, and foreign exchange (-5 ppts) and increased investments in JRNY® (-1 ppt).

•Operating expenses were $81.6 million, an increase of $3.2 million, or 4.1% for the six-months ended September 30, 2021, compared to operating expenses of $78.4 million for the six-months ended September 30, 2020, primarily due to $12.5 million more in advertising, increased JRNY® investments of $5.9 million, a legal settlement of $4.7 million, acquisition expenses of $1.0 million, and partially offset by the $20.7 million Octane Loss on Disposal Group for the six-months ended September 30, 2020. Total advertising expenses were $22.9 million for the six-months ended September 30, 2021, compared to $10.4 million for the six-months ended September 30, 2020.

•Operating income was $15.9 million for the six-months ended September 30, 2021, compared to operating income of $36.9 million for the six-months ended September 30, 2020. The decrease was primarily due to lower gross profit and higher operating expenses.

•Net income was $9.3 million for the six-months ended September 30, 2021, compared to net income of $28.7 million for the six-months ended September 30, 2020.

JRNY® Update

Nautilus Inc. continues to enhance the JRNY® platform, creating differentiated connected-fitness experiences for their members. On September 17, 2021, Nautilus completed its acquisition of VAY AG (“VAY”). VAY specializes in computer vision and AI technology and has developed reliable and precise software solutions for human motion analysis using input from a standard RGB (red-green-blue) camera, such as those found on laptops, smartphones, and tablets. With a mission to democratize professional human motion analysis, VAY enables clients in fitness & health to understand and analyze human movement, providing personalized feedback on repetitions and form in real-time. This acquisition will enhance the JRNY® connected-fitness experience by driving innovation and functionality for members, keeping them engaged, and helping them reach their fitness goals.

The Company recently announced that the JRNY® digital fitness platform now includes a video library of instructor-led strength workouts for Bowflex® SelectTech® 552 and 1090 dumbbells, and that, for a limited time, new JRNY® customers will receive a one-year complimentary membership. This marks the latest step in making the JRNY® experience available to more consumers — whether they are using cardio or strength equipment.

The Company also recently introduced the Bowflex® Max Total® 16 cardio machine — the premier model in the popular, one-of-a-kind Max Trainer line — which includes a 16”, embedded HD touch screen that integrates with the enhanced JRNY® digital fitness platform to help members achieve their fitness goals by offering curated workouts and entertainment options that stream while being coached. The Max Trainer has been one of the Company’s all-time best-selling products. This latest offering includes a one-year JRNY® digital fitness platform membership. JRNY® members stay engaged and motivated with unlimited access to voice-coached individualized workouts, world-class trainer-led workouts, and immersive experiences where workouts are paired with Explore the World™ routes. JRNY® also provides integration with other fitness app workouts, which are tracked and saved in the JRNY® member’s journal.

The Company defines JRNY® Members as all individuals who have a JRNY® account and/or subscription, which includes Subscribers, their respective associated members and members who consume free content.

Table of Contents

Forward Looking Guidance

Back Half of Fiscal 2022

•The Company’s revenue for the next few quarters will be compared to record results due to the pandemic’s effect on net sales last year. To gauge continued progress against the expanded addressable market, the Company will be measuring business versus the same period two years ago for the next few quarters.

•The Company expects total company net sales for the back half of fiscal 2022 to be between $290 million and $320 million, a 2-year revenue CAGR of 21% to 27%. Sales guidance reflects $6.0 million to $7.0 million of deferred revenue related to the Company’s plan to continue bundling 12-month JRNY® trials with cardio equipment sales.

•The Company expects global supply chain challenges to continue pressuring gross margins in the back half. Gross margins are expected to be 15 to 17 percentage points lower than the same period last year driven by increased logistics, deferred revenue, and investments in JRNY®.

•The Company was pleased with the results of the JRNY® investments in the 1st Half and plans to increase investments in the back half to accelerate membership acquisition. The Company expects these investments to dilute operating margins by 5 to 6 percentage points.

•The Company expects to increase advertising spend in the 2nd Half by 9 to 11 percentage points as a rate of sales to market the latest connected fitness offerings to remain competitive in share of voice in the upcoming fitness season.

•Lastly, the Company expects to continue investing in the infrastructure needed to scale and expects these investments to dilute operating margins by 4 to 5 percentage points.

•Given these investments and the external macro pressure on gross margin, the Company expects a loss in the back half with negative operating margins in the mid-teens.

•The Company continues to expect full year capital expenditures to be between $12 million and $14 million with the majority earmarked for JRNY® investments.

•The Company is raising their guidance for JRNY® members to 250,000 to 350,000 by the end of FY22

Longer term view, beyond Fiscal 2022

•For fiscal year 2023, the Company expects gross margin to improve to the low 30% range driven by stabilization in the logistics environment and the accretive impact of the higher margin subscription business. Thus, the Company expects to return to positive adjusted EBITDA in fiscal year 2023.

•The Company stated that they have made the strategic decision to accelerate investments in JRNY for the remainder of fiscal 2022 and through fiscal 2023 with a focus on product innovation and marketing. The Company now believes that JRNY will be accretive sooner than previously expected and will accelerate the achievement of their long-term operating margin goal of 15% by one year to FYE 2025, with margins expanding to high teens by FYE 26.

Factors Affecting Our Performance

Our results of operations may vary significantly from period-to-period. Our revenues typically fluctuate due to the seasonality of our industry, customer buying patterns, product innovation, the nature and level of competition for health and fitness products, our ability to procure products to meet customer demand, the level of spending on, and effectiveness of, our media and advertising programs and our ability to attract new customers and maintain existing sales relationships. In addition, our revenues are highly susceptible to economic factors, including, among other things, the overall condition of the economy and the availability of consumer credit in both the U.S. and Canada. The COVID-19 pandemic has created a heightened need for home-fitness products at an unplanned rate. We are unable to estimate the length of time that the short-term increases in demand for many of our home-fitness products will outpace supply and we are accelerating the manufacturing and delivery of key products. We cannot predict the longer-term impacts of COVID-19 and the impact on our results of operations is uncertain. Our gross margins are being impacted by fluctuations in the costs or availability of materials used to manufacture our products, tariffs,

Table of Contents

expedited shipping and transportation costs and product warranty costs. Gross margins may also be affected by fluctuations in cost associated with acquisition or license of products and technologies, product warranty costs, the cost of fuel, foreign currency exchange rates, and changes in costs of other distribution or manufacturing-related services. Our operating profits or losses may also be affected by the efficiency and effectiveness of our organization. Historically, our operating expenses have been influenced by media costs to produce and distribute advertisements of our products on television, websites and other media, facility costs, operating costs of our information and communications systems, product supply chain management, customer support and new product development activities. In addition, our operating expenses have been affected from time-to-time by asset impairment charges, restructuring charges and other significant unusual or infrequent expenses.

As a result of the above and other factors, our period-to-period operating results may not be indicative of future performance. You should not place undue reliance on our operating results and should consider our prospects in light of the risks, expenses and difficulties typically encountered by us and other companies, both within and outside our industry. We may not be able to successfully address these risks and difficulties and, consequently, we cannot assure you of any future growth or profitability. For more information, see our discussion of risk factors located at Part I, Item 1A of our 2020 Form 10-K as supplemented by our quarterly reports on Form 10-Q.

Discontinued Operations

Results from discontinued operations relate to the disposal of our former Commercial business, which was completed in April 2011. We reached substantial completion of asset liquidation as of December 31, 2012. Although there was no revenue related to the former Commercial business in either the 2021 or 2020 periods, we continue to incur product liability and other legal expenses associated with product previously sold into the Commercial channel.

Table of Contents

RESULTS OF OPERATIONS

Results of operations information was as follows (dollars in thousands):


	Three-Months Ended September 30,				Change
	2021		2020		$		%
Net sales	$	137,959	$	155,391	$	(17,432)	(11.2)	%
Cost of sales	95,906		87,453		8,453		9.7	%
Gross profit	42,053		67,938		(25,885)		(38.1)	%
Operating expenses:
Selling and marketing	21,939		19,207		2,732		14.2	%
General and administrative	16,376		8,841		7,535		85.2	%
Research and development	5,688		4,240		1,448		34.2	%
Gain on disposal group	—		(8,345)		8,345		(100.0)	%
Total operating expenses	44,003		23,943		20,060		83.8	%
Operating (loss) income	(1,950)		43,995		(45,945)		(104.4)	%
Other expense:
Interest income	12		1		11
Interest expense	(481)		(253)		(228)
Other, net	94		(376)		470
Total other expense, net	(375)		(628)		253
(Loss) income from continuing operations before income taxes	(2,325)		43,367		(45,692)
Income tax expense	2,242		9,398		(7,156)
(Loss) income from continuing operations	(4,567)		33,969		(38,536)
Loss from discontinued operations, net of taxes	(35)		(131)		96
Net (loss) income	$	(4,602)	$	33,838	$	(38,440)

Table of Contents


	Six-Months Ended September 30,				Change
	2021		2020		$		%
Net sales	$	322,552	$	269,579	$	52,973	19.7	%
Cost of sales	224,994		154,245		70,749		45.9	%
Gross profit	97,558		115,334		(17,776)		(15.4)	%
Operating expenses:
Selling and marketing	43,239		31,653		11,586		36.6	%
General and administrative	27,899		18,156		9,743		53.7	%
Research and development	10,503		7,968		2,535		31.8	%
Loss on disposal group	—		20,668		(20,668)		(100.0)	%
Total operating expenses	81,641		78,445		3,196		4.1	%
Operating income	15,917		36,889		(20,972)		(56.9)	%
Other expense:
Interest income	33		2		31
Interest expense	(795)		(591)		(204)
Other, net	(26)		(261)		235
Total other expense, net	(788)		(850)		62
Income from continuing operations before income taxes	15,129		36,039		(20,910)
Income tax expense	5,680		7,056		(1,376)
Income from continuing operations	9,449		28,983		(19,534)
Loss from discontinued operations, net of taxes	(167)		(255)		88
Net income	$	9,282	$	28,728	$	(19,446)

Table of Contents

Results of operations information by segment and major product lines was as follows (dollars in thousands):


	Three-Months Ended September 30,						Change
	2021			2020			$			%
Net sales:
Direct net sales:
Cardio products(1)	$	22,406		$	44,278		$	(21,872)		(49.4)	%
Strength products(2)	15,447			16,916			(1,469)			(8.7)	%
Direct	37,853			61,194			(23,341)			(38.1)	%

Retail net sales:
Cardio products(1)	$	58,848		$	71,924		(13,076)			(18.2)	%
Strength products(2)	40,305			21,231			19,074			89.8	%
Retail	99,153			93,155			5,998			6.4	%



Royalty	953			1,042			(89)			(8.5)	%
	$	137,959		$	155,391		$	(17,432)		(11.2)	%

Cost of sales:
Direct	$	23,877		$	26,204		$	(2,327)		(8.9)	%
Retail	72,029			61,249			10,780			17.6	%

	$	95,906		$	87,453		$	8,453		9.7	%

Gross profit:
Direct	$	13,976		$	34,990		$	(21,014)		(60.1)	%
Retail	27,124			31,906			(4,782)			(15.0)	%
Royalty	953			1,042			(89)			(8.5)	%
	$	42,053		$	67,938		$	(25,885)		(38.1)	%
Gross profit margin:
Direct	36.9		%	57.2		%	(2,030)		basis points
Retail	27.4		%	34.3		%	(690)		basis points

Contribution:
Direct	$	(1,835)		$	17,588		(19,423)			(110.4)	%
Retail	18,741			23,442			(4,701)			(20.1)	%

Contribution rate:
Direct	(4.8)		%	28.7		%	(3,350)		basis points
Retail	18.9		%	25.2		%	(630)		basis points

(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, VeloCore®, Schwinn® IC4, Max Trainer®, connected-fitness treadmills, other exercise bikes, ellipticals and subscription services.

(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories.

Table of Contents


	Six-Months Ended September 30,						Change
	2021			2020			$			%
Net sales:
Direct net sales:
Cardio products(1)	$	53,836		$	89,863		$	(36,027)		(40.1)	%
Strength products(2)	47,413			21,764			25,649			117.9	%
Direct	101,249			111,627			(10,378)			(9.3)	%

Retail net sales:
Cardio products(1)	148,772			120,935			27,837			23.0	%
Strength products(2)	70,865			35,168			35,697			101.5	%
Retail	219,637			156,103			63,534			40.7	%






Royalty	1,666			1,849			(183)			(9.9)	%
	$	322,552		$	269,579		$	52,973		19.7	%
Cost of sales:
Direct	$	62,759		$	49,114		$	13,645		27.8	%
Retail	162,235			105,131			57,104			54.3	%

	$	224,994		$	154,245		$	70,749		45.9	%
Gross profit:
Direct	$	38,490		$	62,513		$	(24,023)		(38.4)	%
Retail	57,402			50,972			6,430			12.6	%
Royalty	1,666			1,849			(183)			(9.9)	%
	$	97,558		$	115,334		$	(17,776)		(15.4)	%

Gross profit margin:
Direct	38.0		%	56.0		%	(1,800)		basis points
Retail	26.1		%	32.7		%	(660)		basis points

Contribution:
Direct	$	4,924		$	34,583		$	(29,659)		(85.8)	%
Retail	40,831			35,055			5,776			16.5	%

Contribution rate:
Direct	4.9		%	31.0		%	(2,610)		basis points
Retail	18.6		%	22.5		%	(390)		basis points

(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories.

Sales and Gross Profit

Direct Segment

Net sales were $37.9 million for the three-month period ended September 30, 2021, compared to $61.2 million, a decline of 38.1%, versus the same period in 2020. Demand trends and sales results for the quarter were more in line with pre-pandemic seasonality.

Cardio sales declined 49.4% versus the same period in 2020. Lower sales were primarily driven by lower bike sales, partially offset by increased sales of treadmills and the Max M9, which was the Direct segment’s best-selling model. Strength product sales declined 8.7% versus the same period in 2020. Lower sales were primarily driven by lower sales of Bowflex® Home Gyms partially offset by increased sales of SelectTech® weights.

Table of Contents

Given the improvement in the Company’s inventory position and the ability to fulfill orders within the quarter, the Direct segment's backlog as of September 30, 2021 is down to $1.1 million compared to $26.5 million as of March 31, 2021. These amounts represent unfulfilled consumer orders net of current promotional programs and sales discounts.

Gross profit margins were 36.9% for the three-month period ended September 30, 2021 versus 57.2% for the same period in 2020. The 20.3 ppt decrease in gross margin was primarily driven by: logistics (-13 ppts), increased investments in JRNY® (-5 ppts) and commodities, components, and foreign exchange (-2 ppts). Gross profit was $14.0 million, down 60.1% versus the same period in 2020.

Segment contribution loss was $1.8 million for the three-month period ended September 30, 2021, compared to income of $17.6 million for the same period in 2020. The decline was primarily driven by lower gross profit, including increased investments in JRNY®, partially offset by decreased media spend. Advertising expenses were $6.8 million compared to $8.0 million for the same period in 2020.

Comparison of Segment Results for the Six-Month Period Ended September 30, 2021 to the Six-Month Period Ended September 30, 2020

Net sales for the six-month period ended September 30, 2021 were $101.2 million, down 9.3% versus the same period in 2020. Decreased sales were driven primarily by cardio products which declined by 40.1% versus the same period in 2020, due to lower sales of bikes and partially offset by increased sales of treadmills and max trainers. Strength products sales grew 117.9% versus the same period in 2020 driven by SelectTech® weights and benches.

Gross profit margin for the six-month period ended September 30, 2021 were 38.0% down from 56.0% for the same period in 2020. The 18.0 ppt decrease in gross profit margin was primarily driven by: logistics (-12 ppts), commodities, components, and foreign exchange (-3 ppts) and increased investments in JRNY® (-3 ppts). Gross profit was $38.5 million, a decrease of 38.4% versus the same period in 2020.

Combined consumer credit approvals by our primary and secondary U.S. third-party financing providers for the second quarter of 2021 were 56.1%, compared to 48.5% for the same period in 2020. The increase in approvals reflects higher credit quality applications.

Retail Segment

Net sales for the three-month period ended September 30, 2021 were $99.2 million, up 6.4%, from $93.2 million for the same period in 2020, or 18.6% excluding sales related to the Octane brand. Retail segment sales outside the United States and Canada grew 42%, or 57% excluding Octane. Due to the severe shortage of shipping containers, some factory fulfilled orders, representing over $22 million in revenue, did not ship as planned in late September. 56% of those orders shipped in October.

Cardio sales for the three-month period ended September 30, 2021 decreased by 18.2%, excluding sales related to Octane net sales were down 5.6%, compared to the same period in 2020. Lower sales were primarily driven by bikes and ellipticals. Strength product sales grew by 89.8%, led by the popular SelectTech® weights.

Gross profit margins were 27.4% for the three-month period ended September 30, 2021 down from 34.3% for the same period in 2020. The 6.9 ppt decrease in gross margin was primarily driven by: commodities, components, and foreign exchange (-4 ppts) and logistics (-3 ppts). Gross profit was $27.1 million, a decrease of 15.0% versus the same period in 2020.

Segment contribution income for the three-month period ended September 30, 2021 was $18.7 million, or 18.9% of sales, compared to $23.4 million, or 25.2% of sales for the same period in 2020, primarily driven by lower gross profit.

Comparison of Segment Results for the Six-Month Period Ended September 30, 2021 to the Six-Month Period Ended September 30, 2020

Net sales for the six-month period ended September 30, 2021 were $219.6 million up 40.7% as compared to $156.1 million for the same period in 2020. Excluding sales related to Octane, net sales were up 58.9% versus the same period in 2020. Cardio sales were up 23.0% compared to the same period in 2020, driven primarily by bikes

Table of Contents

and treadmills. Excluding sales related to Octane, cardio sales were up 44.4% versus the same period in 2020. Strength sales were up 101.5% compared to the same period in 2020, driven primarily SelectTech® weights.

Gross profit margin for the six-month period ended September 30, 2021 were 26.1%, down from 32.7% for the same period in 2020. The 6.6 ppt decrease in gross profit margin was primarily driven by: commodities, components, and foreign exchange (-4 ppts) and logistics (-3 ppts). Gross profit was $57.4 million, an increase of 12.6% versus the same period in 2020.

Segment contribution income for the six-month period ended September 30, 2021 was $40.8 million compared to $35.1 million, or 18.6% of sales for the six-month period ended September 30, 2020, primarily driven by higher gross profit.

Royalty

Royalty income decreased by $0.1 million, or 8.5%, to $1.0 million for the three-month period ended September 30, 2021, compared to the same period of 2020, primarily due to royalty settlements.

Royalty income decreased by $0.2 million, or 9.9%, to $1.7 million for the six-month period ended September 30, 2021, compared to the same period of 2020, primarily due to royalty settlements.

Selling and Marketing

Selling and marketing expenses include payroll, employee benefits, and other headcount-related expenses associated with sales and marketing personnel, and the costs of media advertising, promotions, trade shows, seminars, sales incentives related to our our JRNY® platform and other programs.

Selling and marketing information was as follows (dollars in thousands):


	Three-Months Ended September 30,						Change
	2021			2020			$		%
Selling and marketing	$	21,939		$	19,207		$	2,732	14.2%
As % of net sales	15.9		%	12.4		%


	Six-Months Ended September 30,						Change
	2021			2020			$		%
Selling and marketing	$	43,239		$	31,653		$	11,586	36.6%
As % of net sales	13.4		%	11.7		%

The increase in selling and marketing expenses for the three-month period ended September 30, 2021 compared to the same period of 2020 was primarily related to $5.3 million in brand advertising. The increase in selling and marketing expenses for the six-month period ended September 30, 2021 compared to the same period of 2020 was primarily related to $8.1 million in brand advertising.

Media advertising expense is the largest component of selling and marketing and was as follows (dollars in thousands):


	Three-Months Ended September 30,				Change
	2021		2020		$		%
Media advertising - Direct	$	6,776	$	8,017	$	(1,241)	(15.5)%
Media advertising - Brand	5,279		—		5,279		*
Total advertising	$	12,055	$	8,017	$	4,038	50.4%

Table of Contents

*Not meaningful


	Six-Months Ended September 30,				Change
	2021		2020		$		%
Media advertising - Direct	$	14,792	$	10,402	$	4,390	42.2%
Media advertising - Brand	8,087		—		8,087		*
Total advertising	$	22,879	$	10,402	$	12,477	119.9%

*Not meaningful

The decrease in media advertising for Direct for the three-month period ended September 30, 2021 compared to the same period of 2020 was primarily due the launch of the Bowflex® VeloCore® bike last year. The increase in media advertising for Direct for the six-month period ended September 30, 2021 compared to the same period of 2020 was primarily due to the return to normalized levels of media spend.

General and Administrative

General and administrative expenses include payroll, employee benefits, stock-based compensation expense, and other headcount-related expenses associated with finance, legal, facilities, certain human resources and other administrative personnel, acquisition costs and other administrative fees.

General and administrative was as follows (dollars in thousands):


	Three-Months Ended September 30,						Change
	2021			2020			$		%
General and administrative	$	16,376		$	8,841		$	7,535	85.2%
As % of net sales	11.9		%	5.7		%


	Six-Months Ended September 30,						Change
	2021			2020			$		%
General and administrative	$	27,899		$	18,156		$	9,743	53.7%
As % of net sales	8.6		%	6.7		%

The increase in general and administrative expenses for the three-month period ended September 30, 2021 compared to the same period of 2020 was primarily due to a $4.7 million loss contingency related to a legal settlement for a class action lawsuit, $1.7 million increase in personnel expenses and acquisition costs of $0.8 million.

The increase in general and administrative expenses for the six-month period ended September 30, 2021 compared to the same period of 2020 was primarily due to a $4.7 million loss contingency related to a legal settlement for a class action lawsuit, $3.4 million increase in personnel expenses and acquisition costs of $1.0 million.

Research and Development

Research and development expenses include payroll, employee benefits, other headcount-related expenses and information technology associated with product development.

Research and development was as follows (dollars in thousands):

Table of Contents


	Three-Months Ended September 30,						Change
	2021			2020			$		%
Research and development	$	5,688		$	4,240		$	1,448	34.2%
As % of net sales	4.1		%	2.7		%


	Six-Months Ended September 30,						Change
	2021			2020			$		%
Research and development	$	10,503		$	7,968		$	2,535	31.8%
As % of net sales	3.3		%	3.0		%

The increases in research and development expenses for the three and six-month periods ended September 30, 2021, as compared to the same periods of 2020, were driven primarily by increased investments in JRNY®, our digital platform.

(Gain) Loss on Disposal Group

The (gain) loss on disposal group for the three and six-month periods ended September 30, 2020 related to the disposal of our Octane Business in 2020.

Operating (Loss) Income

Operating loss for the three-months ended September 30, 2021 was $2.0 million, a decrease of $46.0 million, or 104.4%, as compared to an operating income of $44.0 million compared to the same period of 2020. The decrease was primarily due to lower gross profit and increased operating expenses as discussed in more detail above.

Operating income for the six-months ended September 30, 2021 was $15.9 million, a decrease of $21.0 million, or 56.9%, as compared to an operating income of $36.9 million compared to the same period of 2020. The decrease was primarily due to lower gross profit and increased operating expenses as discussed in more detail above.

Other, Net

Other, net relates to the effect of exchange rate fluctuations with the U.S. and our foreign subsidiaries.

Income Tax Expense

Income tax provision includes U.S. and international income taxes, and interest and penalties on uncertain tax positions.

Income tax expense was as follows (dollars in thousands):


	Three-Months Ended September 30,						Change
	2021			2020			$		%
Income tax expense	$	2,242		$	9,398		$	(7,156)	(76.1)%
Effective tax rate	(96.4)		%	21.7		%


	Six-Months Ended September 30,						Change
	2021			2020			$		%
Income tax expense (benefit)	$	5,680		$	7,056		$	(1,376)	(19.5)%
Effective tax rate	37.5		%	19.6		%

Income tax expense for the three-months ended September 30, 2021 was primarily due to the non-deductible GAAP book expenses that are not allowed for income tax purposes. Such expenses were incurred in the second quarter as a result of our acquisition of VAY, consequently increasing the effective tax rate for the same period. Income tax expense for the three-months ended September 30, 2020 was as a result of the profit generated in U.S.

Table of Contents

Income tax expense for the six-months ended September 30, 2021 was primarily a result of the profit generated in the U.S combined with the aforementioned non-deductible GAAP book expenses incurred during the second quarter. The lower effective tax rate from continuing operations for the six-months ended September 30, 2020 was primarily due to the 14% rate benefit of net operating loss carry-backs as a result of the enactment of the CARES Act.

(Loss) Income from Continuing Operations

Loss from continuing operations was $4.6 million for the three-months ended September 30, 2021, or -$0.15 per diluted share, compared to income from continuing operations of $34.0 million, or $1.05 per diluted share, for the three-months ended September 30, 2020. The decrease in income from continuing operations was primarily due to lower gross profit and higher operating expenses as discussed in more detail above.

Income from continuing operations was $9.4 million for the six-months ended September 30, 2021, or $0.29 per diluted share, compared to $29.0 million, or $0.90 per diluted share, for the six-months ended September 30, 2020. The decrease was primarily due to lower gross profit and increased operating expenses as discussed in more detail above.

Net (Loss) Income

Net loss was $4.6 million for the three-months ended September 30, 2021, compared to net income of $33.8 million for the three-months ended September 30, 2020. Net loss per diluted share was -$0.15 for the three-months ended September 30, 2021, compared to net income per diluted share of $1.04 for the three-months ended September 30, 2020.

Net income was $9.3 million for the six-months ended September 30, 2021, compared to net income of $28.7 million for the six-months ended September 30, 2020. Net income per diluted share was $0.29 for the six-months ended September 30, 2021, compared to net income per diluted share of $0.90 for the six-months ended September 30, 2020.

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our levels of revenue, the timing and extent of spending on research and development efforts and other business initiatives, the expansion of sales and marketing activities, the timing of new product introductions, market acceptance of our products, and overall economic conditions. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in additional dilution to our shareholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations.

As of September 30, 2021, we had $21.5 million of cash, cash equivalents, restricted cash, and $49.0 million was available for borrowing under the ABL Revolving Facility, compared to $113.2 million of cash, cash equivalents, restricted cash and available-for-sale securities, and $54.4 million available for borrowing under the ABL Revolving Facility as of March 31, 2021. We expect our cash, cash equivalents, restricted cash and amounts available for borrowing under our Credit Facility as of September 30, 2021, along with cash expected to be generated from operations, to be sufficient to fund our operating and capital requirements for at least twelve months from September 30, 2021.

Cash used in operating activities was $56.8 million for the six-month period ended September 30, 2021, compared to cash provided in operating activities of $63.6 million for the six-month period ended September 30, 2020. The decrease in cash flows from operating activities for the six-month period ended September 30, 2021 as compared to the same period of 2020 was primarily due to changes in our operating assets and liabilities discussed below, as well as the decrease in net income.

Trade receivables were basically flat at $88.7 million as of September 30, 2021 and March 31, 2021, primarily due to timing of customer payments on decreased sales.

Inventory was $162.7 million as of September 30, 2021, compared to $68.1 million as of March 31, 2021. The increase in inventory was driven by the strategic decision to increase on-hand inventory levels for the holiday season given continued disruption in global logistics. About 40% of inventory as of September 30, 2021 was in-transit.

Prepaid and other current assets decreased by $12.7 million to $13.1 million, compared to $25.8 million as of March 31, 2021, primarily related to other short-term deposits for inventory.

Trade payables increased by $16.4 million to $115.2 million as of September 30, 2021, compared to $98.9 million as of March 31, 2021, primarily due to timing of payments for inventory.

Accrued liabilities increased by $2.8 million to $22.4 million as of September 30, 2021, compared to $19.6 million as of March 31, 2021, primarily due to an accrued loss contingency related to a class action lawsuit legal settlement.

Cash provided by investing activities of $41.7 million for the six-month period ended September 30, 2021 was primarily due to proceeds from sales and maturities of available-for-sale securities partially offset by the $26.8 million acquisition of VAY. We anticipate spending between $12.0 million and $14.0 million in fiscal 2022 for digital platform enhancements, systems integration, and production tooling.

Cash provided by financing activities was $1.6 million for the six-month period ended September 30, 2021 was primarily related to proceeds from long-term debt.

Table of Contents

Financing Arrangements

On October 29, 2021, we amended our Credit Agreement. The amendment increased the aggregate principal amount available under the ABL Revolving Facility from $55.0 million to $100.0 million ("Revolver"), subject to a borrowing base. The maturity date of the Credit Facility was extended to October 29, 2026. The unamortized balance on the Term Loan was $11.5 million, as of the effective date of the Amendment, and will amortize on a new 60-month straight line basis to coincide with the extended maturity date.

On May 13, 2021, we amended the January 31, 2020 Credit Agreement with Wells Fargo Bank, National Association (“Wells Fargo”) and lenders from time to time party thereto (collectively with Wells Fargo the “Lenders”) (the “Credit Agreement”), pursuant to which the Lenders have agreed, among other things, to make available to us an asset-based revolving loan facility in the aggregate principal amount of up to $55.0 million, subject to a borrowing base (the “ABL Revolving Facility”), and a term loan facility in the aggregate principal amount of $15.0 million (the “Term Loan Facility” and together with the ABL Revolving Facility, the “Credit Facility"), in each case, as such amounts may increase or decrease in accordance with the terms of the Credit Agreement. Several key features have been beneficially amended including permanently removing the $7.5 million minimum liquidity covenant and minimum EBITDA covenant that was scheduled to commence February 1, 2022. The Credit Facility now contains a single market-based 1.0x springing fixed charge coverage ratio tested only when availability is less than the greater of $6.0 million and 12.5% of the Loan Cap, as defined in the Credit Agreement. Various borrowing base definitions and limits were also amended that will result in improved availability under the asset-based revolver. In addition to the above structural improvements, the interest rate on the Term Loan Facility was reduced to LIBOR plus 4.50% versus 5.00%. The Term Loan Facility continues to contain amortization as originally scheduled. The repayment of obligations under the Credit Agreement is secured by substantially all of our assets. Principal and interest amounts are required to be paid as scheduled.Interest on the ABL Revolving Facility will accrue at LIBOR plus a margin of 1.75% to 2.25% (based on average quarterly availability) and interest on the Term Loan Facility will accrue at LIBOR plus 4.50%. As of September 30, 2021, our interest rate was 1.83% for the ABL Revolving Facility and 4.58% for the Term Loan Facility.

Off-Balance Sheet Arrangements

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of September 30, 2021, we had approximately $78.0 million, compared to $216.3 million as of March 31, 2021 in non-cancellable market-based purchase obligations, primarily to secure additional factory capacity for inventory purchases in the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses. The decrease in purchase obligations was primarily due to receipt of inventory ordered for the fitness season.

Table of Contents

with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnifications vary from contract to contract, and generally a maximum obligation is not stated. We hold insurance policies that mitigate potential losses arising from certain types of indemnifications. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows, and therefore, no liabilities were recorded at September 30, 2021.

SEASONALITY

We expect our revenue from fitness equipment products to vary seasonally. Sales are typically strongest in the fourth quarter and are generally weakest in the second quarter. We believe that consumers tend to be involved in outdoor activities during the spring and summer months, including outdoor exercise, which impacts sales of indoor fitness equipment. This seasonality can have a significant effect on our inventory levels, working capital needs and resource utilization.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our critical accounting policies have not changed from those discussed in our 2020 Form 10-K.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 1 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 for a discussion of recent accounting pronouncements.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate and Foreign Exchange Risk

Our exposure to market risk from changes in interest rates relates primarily to our cash equivalents, derivative assets and variable-rate debt obligations. Our cash equivalents mature within three-months or less from the date of purchase. Marketable securities with original maturities of greater than three-months and remaining maturities of less than one year are classified as short-term investments. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. We have classified our marketable securities as available-for-sale and, therefore, we may choose to sell or hold them as changes in the market occur. Because of the short-term nature of the instruments in our portfolio, a decline in interest rates would reduce our interest income over time, and an increase in interest rates may negatively affect the market price or liquidity of certain securities within the portfolio.

Our ABL Revolving Facility and Term Loan Facility generally charge interest based on a benchmark rate such as LIBOR. Fluctuations in short-term interest rates may cause interest payments on term loan principal and drawn amounts on the revolving line to increase or decrease. As of September 30, 2021, the outstanding balances on our ABL Revolving Facility and Term Loan Facility totaled $17.5 million.

We enter into foreign exchange forward contracts to offset the earnings impacts of exchange rate fluctuations on certain monetary assets and liabilities. Total notional amounts outstanding as of September 30, 2021 were $42.3 million.

A hypothetical 10% increase in interest rates, or a 10% movement in the currencies underlying our foreign currency derivative positions, would have material impacts on our results of operations, financial position or cash flows. We do not enter into derivative instruments for any purpose other than to manage our interest rate or foreign currency exposure. That is, we do not engage in interest rate or currency exchange rate speculation using derivative instruments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, our management, including the Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer, have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report, our disclosure controls and procedures are effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the requisite time periods specified in the applicable Securities and Exchange Commission rules and forms, and that it is accumulated and communicated to our management, including our Principal Executive Officer Principal Financial Officer, and Principal Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three-months ended September 30, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, in the ordinary course of business, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur. As of September 30, 2021, we accrued $4.7 million for a contingent loss related to a legal settlement involving a class action lawsuit related to the advertisement of our treadmills. The settlement includes damages, a one-year free membership to JRNY®, and administrative fees and is reflected in Accrued liabilities and Other long-term liabilities on the face of our Consolidated Balance Sheets.

As of the date of filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.

Item 1A. Risk Factors

We operate in an environment that involves a number of risks and uncertainties. The risks and uncertainties described in our 2020 Form 10-K are not the only risks and uncertainties to which we are subject, and there may be other risk and uncertainties that are not currently considered material or are not known to us that could impair our business or operations. If any of the risks described in our 2020 Form 10-K actually occur, our business, operating results and financial position could be adversely affected. There have been no material changes to the risk factors as set forth in our 2020 Form 10-K.

Table of Contents

Item 6. Exhibits

The following exhibits are filed herewith and this list is intended to constitute the exhibit index:


Exhibit No.						Description

3.1						Amended and Restated Articles of Incorporation - Incorporated by reference to Exhibit A to Schedule 14A, as filed with the Commission on April 22, 2008.

3.2						Amended and Restated Bylaws - Incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, as filed with the Commission on April 5, 2005.

3.3						Amendment to Amended and Restated Bylaws of the Company - Incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, as filed with the Commission on January 31, 2007.

10.1						Third Amendment to Credit Agreement dated October 29 , 2021, by and between Nautilus, Inc. and Wells Fargo Bank, National Association - Incorporated by reference to Exhibit 10.1 of our Form 8 -K dated O ctober 29, 20 21 filed with the Commission on November 4, 2021 .


31.1						Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

31.2						Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

32.1						Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH						XBRL Taxonomy Extension Schema Document

101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF						XBRL Taxonomy Extension Definition Linkbase Document

101.LAB						XBRL Taxonomy Extension Label Linkbase Document

101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document

* Indicates management contract, compensatory agreement or arrangement, in which our directors or executive officers may participate.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	NAUTILUS, INC.
	(Registrant)

November 9, 2021	By:	/S/ James Barr IV
Date		James Barr IV
		Chief Executive Officer


	NAUTILUS, INC.
	(Registrant)

November 9, 2021	By:	/S/ Aina E. Konold
Date		Aina E. Konold
		Chief Financial Officer

Document

Exhibit 31.1

CERTIFICATION

I, James Barr IV, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nautilus, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


November 9, 2021	By:	/s/ James Barr IV
Date		James Barr IV
		Chief Executive Officer

Document

Exhibit 31.2

CERTIFICATION

I, Aina E. Konold, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nautilus, Inc.;

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


November 9, 2021	By:	/s/ Aina E. Konold
Date		Aina E. Konold
		Chief Financial Officer

Document

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of Nautilus, Inc., a Washington corporation (the “Company”), do hereby certify that:

To our knowledge, the Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


November 9, 2021	By:	/s/ James Barr IV
Date		James Barr IV
		Chief Executive Officer


November 9, 2021	By:	/s/ Aina E. Konold
Date		Aina E. Konold
		Chief Financial Officer